HT-3951 vs. Placebo in Stroke Rehabilitation "RESTORE"

Recruiting

Phase 2 Results N/A

Summary of Purpose

This is a randomized, double-blind, placebo-controlled parallel group outpatient study that will utilize standard stroke rehabilitation outcome measures, as well as fMRI techniques in a subset of subjects, to evaluate the effect of HT-3951 on motor recovery and behavior in medically stable subjects following ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 July 2016.

1 Feb 2016 6 Aug 2015 1 Sep 2016 1 Sep 2016 1 Jul 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts